10/28/2026
Pharma giants invest billions in psychedelics despite hurdles
Psychedelics like MDMA and psilocybin gain traction amid regulatory challenges.
Topic archive
2 stories
10/28/2026
Psychedelics like MDMA and psilocybin gain traction amid regulatory challenges.
8/26/2026
The move promotes open science and could influence future psychedelic research.